Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Recs

0
Player Avatar turingmouse (69.19) Submitted: 2/12/2007 2:05:24 AM : Outperform Start Price: $9.22 ACHN Score: -18.33

took to much of a beating on hep-c trial news. should outperform.

Featured Broker Partners


Advertisement